Previous study has shown that SKA2 co-localizes and interacts with glucocorticoid receptor (GR), and enhancing the cancer cell proliferative response to IGF-1 exposure 8, suggesting that SKA2 should be capable of regulating its target genes to augment cancer cell progression. This evidence concerns the gene NR3C1 and cancer.